« Back
Home /
BIBR 1087 SE

BIBR 1087 SE

Item no.	HY-W004360-10mg
Manufacturer	MedChem Express
CASRN	212321-78-3
Amount	10 mg
Quantity options	10mM/1mL 10 mg 25 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	97.0
Formula	C32H37N7O5
Citations	[1]Stangier J, et al. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. J Clin Pharmacol. 2008 Dec;48(12):1411-9.
Smiles	N=C(C1=CC=C(C=C1)NCC2=NC3=CC(C(N(CCC(O)=O)C4=NC=CC=C4)=O)=CC=C3N2C)NC(OCCCCCC)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Desethyl Dabigatran Etexilate
Available
Product Description	BIBR 1087 SE is an intermediate metabolite of dabigatran etexilate.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	599.68
Clinical Information	No Development Reported
Manufacturers Research Area	Metabolic Disease; Inflammation/Immunology
Solubility	DMSO : 250 mg/mL (ultrasonic)
Target	Others
Manufacturers Target	Others
Manufacturers Pathway	Others
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-W004360-10mg-safety-datasheet.pdf